#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prodromal Alzheimer's disease Congenital cystic kidney disease Immune thrombocytopenia Vulval cancer Choroidal dystrophy Diabetes insipidus B-cell small lymphocytic lymphoma refractory Toxic epidermal necrolysis Idiopathic pulmonary fibrosis Palmar-plantar erythrodysaesthesia syndrome Chronic myeloid leukaemia (in remission) Neuronal ceroid lipofuscinosis Diffuse large B-cell lymphoma recurrent Malignant peritoneal neoplasm Arteriovenous malformation More trials…

    Learn about Rare Diseases

    Combined immunodeficiency – Life with Disease Mucopolysaccharidosis II – Trials in Disease Primary mediastinal large B-cell lymphoma – Treatment Combined immunodeficiency Hereditary motor and sensory neuropathy – Trials in Disease Atypical haemolytic uraemic syndrome – Diagnostics Glycogen storage disease type V – Basic Information Advanced systemic mastocytosis – Trials in Disease IgA nephropathy – Basic Information Basal cell naevus syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lumasiran Choriogonadotropin Alfa Linvoseltamab Zinc Acetate Dihydrate Annamycin Star-0215 Enoxaparin Sodium Sultiame Nicotine Dasatinib Sevoflurane Fosfomycin Trometamol FLUORIDE Antiemetics And Antinauseants Bi 706321 Dexamethasone Acetate ELTANEXOR Isotretinoin Necvax-Neo1 Envudeucitinib More therapies…

    Learn about Your Condition

    Andersen-Tawil syndrome Autoimmune hepatitis Hypoxia Pituitary tumour benign Fontan procedure Renal cancer metastatic Uterine leiomyoma Follicular lymphoma stage II Cutaneous sarcoidosis Pain in extremity Retinopathy of prematurity Dystonic tremor Osteogenesis imperfecta VEXAS syndrome IgA nephropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • A Study Comparing Eltrombopag Tablets in Healthy Volunteers to Test if Two Forms of the Medicine Work the Same Way in the Body After Taking with Food

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Aplastic anaemia
    • Thrombocytopenia
    Portugal

  • A Study of Ianalumab and Eltrombopag for Patients with Primary Immune Thrombocytopenia Who Did Not Respond Well to or Relapsed After Steroid Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Eltrombopag
    • Entecavir
    • Ianalumab
    Austria Belgium Czechia France Germany Hungary +5

  • Study on the Effects of Tebapivat and AG-946 in Patients with Sickle Cell Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Ag-946 Phosphate
    Belgium France Ireland The Netherlands

  • Evaluating Sonrotoclax Alone and Combined with Zanubrutinib for Patients with Previously Untreated or Relapsed/Refractory Waldenström Macroglobulinemia

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Waldenstrom’s macroglobulinaemia
    • Waldenstrom’s macroglobulinaemia refractory
    Investigated Drugs:
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Zanubrutinib
    France Greece Italy Spain

  • Study on the Use of Indocyanine Green to Assess Lymphatic Vessel Porosity in Women with Lipedema

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Indocyanine Green
    Belgium

  • Study on the Safety and Effectiveness of Crovalimab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

    Not recruiting

    2 1
    Investigated Diseases:
    • Paroxysmal nocturnal haemoglobinuria
    Investigated Drugs:
    • Crovalimab
    France Germany Hungary Italy
Previous Page
1 … 45 46 47 48 49 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!